NYSE ARCA | ETF
The fund invests primarily in a diverse group ofU. S. companies in market sectors and industry groups the portfolio managers expect to appreciate in value if theU. S. inflation rate rises or is believed to be rising.
Under normal market conditions, the fund will invest at least 80% of its assets in equity securities.
The fund may invest in companies of all market capitalizations.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BRK-B | Berkshire Hathaway Inc | Financial Services | Insurance - Diversified | 6.75% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 5.10% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.38% |
| PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 3.86% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.63% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 2.71% |
| KO | The Coca-Cola Company | Consumer Defensive | Beverages - Non-Alcoholic | 2.44% |
| PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 2.37% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.13% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 1.84% |
| COP | ConocoPhillips | Energy | Oil & Gas E&P | 1.66% |
| PGR | Progressive Corp | Financial Services | Insurance - Property & Casualty | 1.55% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.38% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.29% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.22% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.16% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.15% |
| CL | Colgate-Palmolive Company | Consumer Defensive | Household & Personal Products | 1.09% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 1.07% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.04% |